论文信息 - NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma. - 字舞流文

NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma.

K. Aldape | M. Gilbert | M. Mehta | P. Wen | A. Sloan | I. Barani | F. Iwamoto | Peixin Zhang | M. Won | L. Rogers | A. Voloschin | J. Groot | R. Raval | Jing Wu